{"id":13279,"date":"2010-09-03T10:30:00","date_gmt":"2010-09-03T08:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/mega-multa-per-600-milioni-per-il-farmaco-botox\/"},"modified":"2010-09-03T10:30:00","modified_gmt":"2010-09-03T08:30:00","slug":"mega-multa-per-600-milioni-per-il-farmaco-botox","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/mega-multa-per-600-milioni-per-il-farmaco-botox\/","title":{"rendered":"Mega fine of 600 million for the drug Botox"},"content":{"rendered":"

\"\"<\/p>\n

Washington - The manufacturer of Botox (capable of "paralyzing" wrinkles) will pay a huge fine to the US government  <\/span>$600 million for promoting the drug's misuse between 2000 and 2005. Allergan -- which manufactures and markets the product -- admitted to running promotional campaigns for the sale and use of Botox for a variety of ailments for which it had never been approved by the Food and Drug Administration (FDA). For example to combat the spasms caused by infantile cerebral palsy. <\/p>\n

<\/span><\/p>\n

\"\" \u2013 September 3, 2010 \u2013 p. 11<\/p>\n

<\/em><\/span><\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

Washington – L’azienda produttrice del Botox (capace di “paralizzare” le rughe) pagherà una mega multa al governo americano  pari a 600 milioni di dollari per aver promosso l’uso improprio del medicinale fra il 2000 ed il 2005. Allergan – che manifattura e commercializza il prodotto – ha ammesso di aver condotto campagne promozionali per la …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-13279","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=13279"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13279\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=13279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=13279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=13279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}